Carlsmed CARL
NASDAQ CARL
$14.50 +0.74 (+5.37%)
As of: Oct 2, 2026 · 2:20 PM EDT

Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2026)

Updated

Carlsmed (CARL) posted Net Equity Issued and Repurchased of $36,000 for Q2 2026, down 91.7% from the prior quarter.

Analysis

Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Carlsmed was $82.02 million, up 217.8% year-over-year; for FY2025, it was $93.47 million, up 78.9% from FY2024.

  • In prior years, Carlsmed's Net Equity Issued and Repurchased was $52.26 million in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 3.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 65.60 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 20.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 5.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 53.80 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Carlsmed 383.07 Mn -76.53 Mn 14.54 Mn 36,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36,000.00
Mar 31, 2026 436,000.00
Sep 30, 2025 81.55 Mn
Mar 31, 2025 11.92 Mn
Dec 31, 2024 -33,000.00
Sep 30, 2024 13.92 Mn
API Access

Carlsmed Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CARL&period=max&api_key=YOUR_API_KEY